Search Browse Earnings

SEELOS THERAPEUTICS, INC. — SlamSEC

SEELOS THERAPEUTICS, INC.

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.2M

FY 2023

Adj. EBITDA

-$70.8M

-3213.8% margin

FY 2023

Net Income

-$73.5M

-3337.9% margin

FY 2023

EPS (Diluted)

-$20.74

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$10.3M

FY 2021

Total Debt

$20.4M

FY 2023

Net Debt

$10.1M

FY 2023

Enterprise Value

—

Debt / EBITDA

-0.1x

FY 2023

EV / EBITDA

—

Employees

—

CFO

Golembiewski Michael Joseph